Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Deutsche Bank Reiterates Hold Rating on AstraZeneca (AZN:LN) (AZN)
-
-
-
-
-
-
-
Form F-6EF ASTRAZENECA PLC Filed by: Deutsche Bank Trust Co Americas/ ADR Group
-
-
-
-
-
-
-
AstraZeneca (AZN:LN) (AZN) PT Raised to GBp7,800 at Deutsche Bank
-
-
-
-
-
-
-
AstraZeneca (AZN:LN) (AZN) PT Raised to GBp6,500 at Deutsche Bank on SOLO-1 Results.
-
-
-
-
-
-
-
AstraZeneca asthma drug hits goal, to enter competitive market
-
-
-
-
-
-
-
Notable Analyst Rating Changes 05/27: (CSCO) (SPLK) (ODP) Upgraded; (SPLS) (PCYC) (AZN) Downgraded
-
-
-
-
-
-
-
Notable 52-Week Highs and Lows of the Day 06/05: (KNDI) (DANG) (MFRM) High; (VMW) (RIGL) Low
-
55,975 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

